With the time entering 20021,the epidemic prevention and control in China has achieved remarkable results, and the sales of pharmacies have been controlled, so it is difficult to maintain the growth rate of this series of products. Some insiders told Cailian reporter: "It is estimated that the sales volume of Lianhua Qingyi 202 1 year will not change much compared with 2020, and the sales growth rate will enter a bottleneck stage."
At the same time, Yiling Pharmaceutical just met with policy support in the layout of Chinese medicine formula granules and great health, and gained good development opportunities.
A person close to the company told Cailian reporter: "Yiling has built a new Chinese medicine formula granule factory in Hengshui area, and the workshops have been certified and put into production one after another, and the investment in this market may increase in the future."
According to the data, in the fourth quarter of 2065438+2009, Yiling Pharmaceutical invested in the establishment of Hengshui Yiling Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Hengshui Gucheng County Economic Development Zone, with an investment of more than 5 billion yuan. After put into production, it will achieve an annual output of 4,200 tons of Chinese herbal pieces, 4,500 tons of formula granules, 4,500 tons of Chinese herbal extracts, 3 billion Chinese herbal tablets, 654.38 billion Chinese herbal health soft capsules, and 500 tons of health food and health drinks. After the new factory is put into operation, it will enhance the company's production capacity in traditional Chinese medicine extraction, formula granules and traditional Chinese medicine health care products.
Yiling Pharmaceutical Co., Ltd. is a provincial-level pilot enterprise that obtained the qualification of producing Chinese medicine formula granules earlier. At present, the company has approved 646 kinds of Chinese medicine formula granules for clinical research and use in medical institutions in Hebei Province. However, due to the early occupation of hospitals in Hebei by Shenwei Pharmaceutical (2877.HK), under the old pilot rules, cross-regional operation and terminal market penetration were restricted, and the company's business market development progress was slow and its turnover was small.
However, at the end of 20021,the experiment of Chinese medicine formula granules ended and the market was liberalized. Some insiders predict: "The Chinese medicine formula granule market may maintain an annual market growth rate of 15%, and the future market scale may exceed 100 billion." It coincides with the gradual completion of the construction of the company's new Hengshui plant, and the company's early layout time is well connected with the policy dividend period.
In addition, with the favorable policies, the health field of traditional Chinese medicine has also ushered in a golden period of development. At present, with the help of the brand of "Lianhua Qingwen", Yiling Pharmaceutical has created a series of products with Lianhua respiratory health as the core. A series of products, such as Lianhua Qingke Tablets and Lianhua Qingwen Powerful Blasting Beads, have been launched one after another to inhibit bacteria, and at the same time, they have entered the health beverage market through Lianhua Qingfei Series.
The relevant person in charge of the company told Cailian: "We believe that the big health industry has great development potential. At present, there are hundreds of categories in the company's big health industry, and Lianhua series disinfection and protection products also have explosive products. At the beginning of listing, the daily sales exceeded one million. "
In addition to the Lotus series, the company is also laying out the layout in the field of anti-aging and great health. Prior to this, Academician Wu Yiling, the founder of the company, delivered an academic speech on "Anti-aging Research Project of Bazi Bushen Capsule Guided by the Theory of Qi Collateral" at the Summit Forum on Prevention and Treatment of Premature Aging in Traditional Chinese Medicine. According to the company, it is planned to develop bazi kidney-tonifying products into big health products to improve the function of aging and aging-related diseases.